M. H. van Oers - Concepedia

Author

M. H. van Oers

Amsterdam UMC Location University of Amsterdam

Also Known As

M H Van Oers, M H van Oers, M. H. van Oers, M.H. van Oers, M.H.J. Van Oers, Marinus H van Oers, Marinus H. van Oers, Marinus HJ van Oers, Marinus H. van Oers

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location University of Amsterdam University of Amsterdam University Medical Center Utrecht St. Antonius Ziekenhuis Dutch Blood Transfusion Society

About

M. H. van Oers is an author at Amsterdam UMC Location University of Amsterdam specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.5K
2	Health Sciences	4	4	973
3	Cell Biology	4	4	118
4	Engineering	1	1	14
5	Biochemistry	1	1	899

M. H. van Oers

Publications

Citations

H-Index

Page 1

	Year	Citations
Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. Carla E. M. Hollak, Sonja van Weely, M. H. van Oers, Journal of Clinical Investigation Clinical SymptomsImmunologyGlycobiologyPathologyMarked Elevation	1994	899
A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma Henk M. Lokhorst, Bronno van der Holt, Sonja Zweegman, Blood	2009	275
Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. M. H. van Oers, Alexandra Heyden, LA Aarden PubMed Renal PathologyTransplantation MedicineImmunologyRenal InflammationPathology	1988	268
Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma. Marie José Kersten, Michèl R. Klein, A M Holwerda, Journal of Clinical Investigation Hiv-1-specific Immune ExhaustionImmunodeficienciesImmunologyEbv LoadPathology	1997	82
A dual role for both CD40-ligand and TNF-α in controlling human B cell death Susanne M.A. Lens, Kiki Tesselaar, B F den Drijver, The Journal of Immunology	1996	79
Altered EBV Viral Load Setpoint after HIV Seroconversion Is in Accordance with Lack of Predictive Value of EBV Load for the Occurrence of AIDS-Related Non-Hodgkin Lymphoma Erwan Piriou, Karel van Dort, Nening M. Nanlohy, The Journal of Immunology	2004	59
Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop. H C van Zaanen, Richard P. Koopmans, L Aarden, Journal of Clinical Investigation Clinical ImmunologyImmunologyPathologyMetronomic ChemotherapyImmunotherapy	1996	55
ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia Sanne H. Tonino, Jacoline van Laar, M. H. van Oers, Oncogene Hematological MalignancyTumor BiologyMedicineImmunologyNoxa Overcomes Chemoresistance	2010	48
Increased basal glucose production in type 1 Gaucher's disease. Eleonora P.M. Corssmit, Carla E. M. Hollak, Erik Endert, The Journal of Clinical Endocrinology & Metabolism NutritionMetabolic DisorderGlucose ProductionObesityMetabolic Syndrome	1995	37
Expansion of effector T cells associated with decreased PD-1 expression in patients with indolent B cell lymphomas and chronic lymphocytic leukemia Sanne H. Tonino, Pablo J. van de Berg, Si La Yong, Leukemia & lymphoma/Leukemia and lymphoma Lymphoid NeoplasiaT Cell HomeostasisAutoimmune DiseaseChronic Lymphocytic LeukemiaMalignant Blood Disorder	2012	35

Page 1